FFA
description
Transcript of FFA
![Page 1: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/1.jpg)
FFA
Dr Aaron Ng
![Page 2: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/2.jpg)
FFA Principles
• Fluorescence– Stimulated by light of shorter wavelength – Emission of light of longer wavelength
• Flurescein– Excitation peak 490nm– Emit light of about 530nm
![Page 3: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/3.jpg)
FFA Principles: Filters
![Page 4: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/4.jpg)
5 Phases of Angiogram
1.Choroidal (Pre-arterial): 9-15 sec
![Page 5: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/5.jpg)
5 Phases of Angiogram
2.Arterial phase: 1 sec after choroidal phase
![Page 6: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/6.jpg)
5 Phases of Angiogram
3.Arterio-venous (capillary) phase: early venous laminar flow
![Page 7: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/7.jpg)
5 Phases of Angiogram
4a.Venous phase: Laminar venous flow
![Page 8: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/8.jpg)
5 Phases of Angiogram4b.Venous phase – complete filling
•Max perifoveal capillary filling – 20-25 sec
•First pass of fluorescein circulation – 30 sec
![Page 9: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/9.jpg)
5 Phases of Angiogram
5. Late (recirculation) phase
•Absent after 10 min
![Page 10: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/10.jpg)
Timing of FFA phases• Arm to retina (ONH): 7-12s• Posterior ciliary artery 9s• Choroidal flush, cilio-retinal artery 10s• Retinal arterial phase 10-12s• Capillary transition phase 13s• Early venous/lamellar/a-v phase 14-15s• Venous phase 16-17s• Late venous phase 18-20s• Late phase 5-15 min
![Page 11: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/11.jpg)
Foveal dark appearance
- Foveal avascular zone- High density of xanthophyll at the fovea- Foveal RPE larger and rich in melanin and
lipofuscin
![Page 12: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/12.jpg)
Causes of hyperfluorescence
1. Autofluorescence2. Pseudofluorescence3. RPE window defect4. Dye pooling5. Dye leaking6. Tissue staining-disc, drusen, chorioretinal
scar
![Page 13: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/13.jpg)
Autofluorescence
Optic disc drusen
![Page 14: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/14.jpg)
Autofluorescence
Lipofuscin
![Page 15: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/15.jpg)
Autofluorescence
Angioid streaks
![Page 16: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/16.jpg)
RPE window defect
Atrophic ARMD
![Page 17: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/17.jpg)
Dye pooling
Subretinal - CSCR
![Page 18: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/18.jpg)
Dye pooling
Sub-RPE - PED
![Page 19: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/19.jpg)
Dye leaking
Proliferative DR
Cystoid Macula Oedema
![Page 20: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/20.jpg)
Late staining
![Page 21: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/21.jpg)
Causes for hypofluorescence
• Masking of retinal fluorescence– Pre-retinal lesions block all fluorescence– Deeper retinal lesions e.g. intraretinal
haemorrhages and hard exudates block only capillary fluorescence
![Page 22: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/22.jpg)
Pre-retinal lesions
Blockage to all fluorescence
![Page 23: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/23.jpg)
Intraretinal lesions
Hard exudates Intraretinal haemorrhages
![Page 24: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/24.jpg)
Causes for hypofluorescence
• Masking of background choroidal fluorescence– Conditions that block retinal fluorescence– Conditions that block only choroidal
• Sub-retinal or subRPE lesions• Increased RPE density• Choroidal lesions
• Filling defects– Vascular occlusions– Loss of vascular bed (myopic degen, choroidaeraemia)
![Page 25: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/25.jpg)
Increased RPE density
CHRPE
![Page 26: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/26.jpg)
Choroidal naevus
![Page 27: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/27.jpg)
Filling defects
Capillary drop – out in DR (vascular occlusion)
Choroidaeraemia (loss of vascular bed)
![Page 28: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/28.jpg)
CNVM subtypes
![Page 29: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/29.jpg)
Classic
![Page 30: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/30.jpg)
Atypical classic
![Page 31: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/31.jpg)
Occult
![Page 32: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/32.jpg)
Minimally classic
![Page 33: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/33.jpg)
Indocyanine Green Angiography
• Advantages over FFA– Study of choroidal vasculature otherwise
prevented in FFA due to RPE blockage– Near-infrared light utilised penetrates melanin,
xanthophylls, exudates and subretinal blood– Infrared is scattered less cf visible light, thus
suitable in eyes with media opacities– 98% ICG molecules bound to protein, thus
remaining in the blood vessels
![Page 34: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/34.jpg)
ICGA Principles
• Infrared excitation (805nm)• Infrared emission (835nm)
![Page 35: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/35.jpg)
Phases of ICGA• Early phase (first 60 sec
post injection) – choroidal arteries
• Early mid phase (1-3 min) – choroidal veins and retinal vessels
• Late mid phase (3-15 min) – choroidal vessels facing but retinal vessels are still visible
• Late phase (14-45 min) – hypofluorescent choroidal vessels and gradual fading of diffuse hyperfluorescence
![Page 36: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/36.jpg)
Causes for hyperfluorescence
• “Window defect”
• Retinal or choroidal vessel leakage
• Abnormal retinal or choroidal vessels
![Page 37: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/37.jpg)
Causes for hypofluorescence
• Blockage– Pigment, blood, fibrosis, infiltrate, exudate, serous
fluid– PED are predominantly hypofluorescent on ICGA
as cf FFA
• Filling defect– Vascular occlusion– Loss of choroidal or retinal circulation
![Page 38: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/38.jpg)
Clinical indications
• PCV• CSCR• Posterior uveitis (extent of disease
involvement)• Breaks in Bruch’s (lacquer cracks, angiod
streaks)• Contraindication for FFA
![Page 39: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/39.jpg)
CSCR
FFA ICGA
![Page 40: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/40.jpg)
CSCR
![Page 41: FFA](https://reader035.fdocuments.in/reader035/viewer/2022062808/56815448550346895dc259a9/html5/thumbnails/41.jpg)
PCV